推薦產品
化驗
96%
形狀
liquid
折射率
n20/D 1.511 (lit.)
密度
1.194 g/mL at 25 °C (lit.)
SMILES 字串
Fc1cccc(CCl)c1
InChI
1S/C7H6ClF/c8-5-6-2-1-3-7(9)4-6/h1-4H,5H2
InChI 密鑰
XBDXMDVEZLOGMC-UHFFFAOYSA-N
尋找類似的產品？ 前往 產品比較指南
訊號詞
Danger
危險聲明
危險分類
Eye Dam. 1 - Skin Corr. 1B
儲存類別代碼
3 - Flammable liquids
水污染物質分類（WGK）
WGK 3
閃點（°F）
159.8 °F - closed cup
閃點（°C）
71 °C - closed cup
個人防護裝備
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
William L Scott et al.
Journal of combinatorial chemistry, 11(1), 14-33 (2008-12-25)
Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computational stages of D(3) is the global rehearsal of prospective reagents and
Steffen Bugge et al.
European journal of medicinal chemistry, 94, 175-194 (2015-03-15)
An approach for optimization of epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitors using truncated thienopyrimidine structures combined with enzymatic assay has been evaluated. This was done by synthesis and EGFR activity measurement of a series of fragment structures and
William L Scott et al.
Journal of combinatorial chemistry, 11(1), 34-43 (2008-12-25)
For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducibly make new, high quality, molecules with potential for biological activity. This article reports
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務